Search Results 51-60 of 16247 for pharmacogenetics

  1. Comparison of Pharmacogenomic Testing Results Across Companies - Mayo Clinic

    The purpose of this study is to: To evaluate whether the genotypic and phenotypic results for a single subject are the same among companies offering ...

  2. Science Saturday: Moving pharmacogenomics into everyday clinical practice

    After nearly half a century of research, Mayo Clinic is a leader in moving pharmacogenomics into clinical practice. This year pharmacogenomics test results ...

  3. Matthew P. Goetz, M.D. - Doctors and Medical Staff - Mayo Clinic

    2023 - 2024. Chair2024 Scientific Program Subcommittee, Pharmacology, Pharmacogenetics and Pharmacogenomics Subcommittee, Experimental and Molecular ...

  4. Andres J. Acosta, M.D., Ph.D. - Mayo Clinic Faculty Profiles

    The study of genetic polymorphisms associated with gastrointestinal traits and obesity therapy, known as pharmacogenetics and novel pharmacotherapeutics, are a ...

  5. Pharmacogenomics (PGx) Results and Clinical Data of Established Patients with Liver Disease to Assess Current and Future Therapeutic Relevance of PGx Testing - Mayo Clinic

    About this study. The goal of this study is to examine the current and (potential) future therapeutic relevance of PGx testing in established patients with ...

  6. A Study of Pharmacogenomics (PGx) Results and Clinical Data of Patients in the Palliative Medicine Clinic to Assess Current and Future Therapeutic Relevance - Mayo Clinic

    About this study. The goal of this study is to examine the current and (potential) future therapeutic relevance of PGx testing for a group of patients in ...

  7. A Study to Evaluate the Pharmacist Role and Pharmacogenomics in the Care of Seriously Ill Patients - Mayo Clinic

    About this study · The impact that a clinical pharmacist and pharmacogenomic testing has on symptom management; · Patient perceptions, satisfaction and behaviors ...

  8. PREemptive Pharmacogenomic testing for prevention of Adverse drug REactions - Mayo Clinic

    About this study. The purpose of this study is to determine whether the implementation of pre-emptive PGx[HSR1] testing of a panel of clinically relevant ...

  9. Pharmacogenomics and the Potential for Utilization of Testing Results for Patient Care in the Cardiac Surgical Intensive Care Unit - Mayo Clinic

    About this study. The overall goals of this pilot study are to: (1) describe pharmacogenomics (PGx) testing results and identify PGx variants that may ...

  10. Janet E. Olson, Ph.D. - Mayo Clinic Faculty Profiles

    This study recently used pharmacogenetic (PGx) data on 11,000 subjects within the Mayo Clinic Biobank as part of the Right Drug, Right Dose, Right Time ...